The effect of vitamin K4 supplementation on insulin resistance in individuals with type 2 diabetes: a double-blind randomised placebo-controlled clinical trial
European Journal of Nutrition · 2023
DOI: 10.1007/s00394-023-03215-8 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Nutrition, 2023. Verfasst von Amani M Ali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt. amany.mohamed@pharma.cu.edu.eg. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Pharmacy, Cairo University, Cairo University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Purpose
The purpose of this study was to assess the possible clinical effects of vitamin K4 supplementation in individuals with type 2 diabetes namely insulin resistance, glycaemic control, and lipid profile.
Methods
This was a prospective randomised double-blind placebo-controlled clinical trial. A total of 106 patients were randomised to receive either 1 mg of vitamin K4 (menadiol diacetate) or placebo for 24 weeks.
Results
Ninety patients (n = 45 in each study group) were included in the final analysis. After 24 weeks, homeostatic model assessment of insulin resistance (HOMA-IR) (16.54 ± 7.81 vs. 29.09 ± 36.56, P = 0.027) and fasting serum insulin (FSI) (6.86 ± 3.45 vs. 11.13 ± 12.66 µU/ml, P = 0.032) were significantly lower in the vitamin K group compared to placebo. Additionally, triglycerides (TG) (144.94 ± 50.7 vs. 172.8 ± 101.5 mg/dl, P = 0.031) and very low-density lipoproteins (VLDL) levels (28.9 ± 9.88 vs. 34.6 ± 20.30 mg/dl, P = 0.027) decreased significantly in the vitamin K group after 24 weeks compared to baseline. Moreover, more patients in the vitamin K group (35.6%) had their antidiabetic medication doses reduced after 24 weeks compared to placebo (13.3%, P = 0.029).
Conclusion
Vitamin K4 supplementation for 24 weeks is capable of improving insulin resistance and TG levels in individuals with type 2 diabetes. In addition, the improvement in insulin resistance was reflected in the decrease in antidiabetic medication doses. However, it did not affect fasting plasma glucose (FPG) or glycated haemoglobin (HbA 1 c).
Trial registration
The study was registered on clinicaltrials.gov with ID: NCT04285450.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt. amany.mohamed@pharma.cu.edu.eg.
- Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Internal Medicine, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Förderung
- Faculty of Pharmacy, Cairo University
- Cairo University
Zitieren
APA
Ali, A. M., Abbassi, M. M., Sabry, N. A., Fawzi, M., & Mousa, S. (2023). The effect of vitamin K4 supplementation on insulin resistance in individuals with type 2 diabetes: a double-blind randomised placebo-controlled clinical trial. European Journal of Nutrition. https://doi.org/10.1007/s00394-023-03215-8
Vancouver
Ali AM, Abbassi MM, Sabry NA, Fawzi M, Mousa S. The effect of vitamin K4 supplementation on insulin resistance in individuals with type 2 diabetes: a double-blind randomised placebo-controlled clinical trial. European Journal of Nutrition. 2023. doi:10.1007/s00394-023-03215-8
BibTeX
@article{Ali2023,
author = {Ali, Amani M and Abbassi, Maggie M and Sabry, Nirmeen A and Fawzi, May and Mousa, Shrook},
title = {The effect of vitamin K4 supplementation on insulin resistance in individuals with type 2 diabetes: a double-blind randomised placebo-controlled clinical trial},
journal = {European Journal of Nutrition},
year = {2023},
doi = {10.1007/s00394-023-03215-8}
}
EUVIMED